Zylox-Tonbridge Medical Technology Co Ltd Class H 818

Morningstar Rating
€2.06 −0.08 (3.74%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

818 is trading at a LOCK|>%Y@< premium.
Price
€2.06
Fair Value
LOCK|&sw&!d
Uncertainty
LOCK|WnHz
1-Star Price
LOCK|w$#r>F
5-Star Price
LOCK|>%?V>QJ
Economic Moat
LOCK|#%?
Capital Allocation
—

Trading Information

Previous Close Price
€2.14
Day Range
€2.04–2.06
52-Week Range
€1.22–1.22
Bid/Ask
€0.00 / €0.00
Shares Outstanding
329.84M
Market Cap
€679.48M
Volume/Avg
— / —

Key Statistics

Price/Earnings (Normalized)
17.19
Price/Sales
4.47
Dividend Yield (Trailing)
1.35%
Dividend Yield (Forward)
1.35%
Dividend Payment Schedule
Jun
Total Yield
4.51%

Company Profile

Zylox-Tonbridge Medical Technology Co Ltd is principally engaged in providing solutions to patients and physicians with a product portfolio covering peripheral-vascular interventional devices and neurovascular interventional devices in China and other countries. The company's products include Thrombite Clot Retriever Device (Thrombite CRD), Ultrafree Drug Coated PTA Balloon Catheter (Ultrafree DCB), and others. The company derives majority of its revenue from PRC.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Growth
Total Number of Employees
1,214

Valuation

Metric
818
Price/Earnings (Normalized)
17.19
Price/Book Value
1.78
Price/Sales
4.47
Price/Cash Flow
11.65
Price/Earnings
818

Financial Strength

Metric
818
Quick Ratio
4.01
Current Ratio
4.67
Interest Coverage
100.85
Quick Ratio
818

Profitability

Metric
818
Return on Assets (Normalized)
9.18%
Return on Equity (Normalized)
10.59%
Return on Invested Capital (Normalized)
8.94%
Return on Assets
818

Medical Devices Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Abbott Laboratories
ABT
LOCK|?v&<@@LOCK|w?zy$184B
Medtronic PLC
MDT
LOCK|!%##XxyLOCK|K&!F$123B
Stryker Corp
SYK
LOCK|j%BpZGk@LOCK|nK$111B
Boston Scientific Corp
BSX
LOCK|#Fzr$&LOCK|@YWs$61B
Edwards Lifesciences Corp
EW
LOCK|fQcC##&LOCK|##Fl?$53B
GE HealthCare Technologies Inc Common Stock
GEHC
LOCK|!Pjh^&LOCK|<$l$35B
DexCom Inc
DXCM
LOCK|<z^>XhyLOCK|Mx>XK$31B
Koninklijke Philips NV ADR
PHG
LOCK|t@LOCK|?!^$26B
Steris PLC
STE
LOCK|q>$@Z%bLOCK|&ZP%F$22B
Zimmer Biomet Holdings Inc
ZBH
LOCK|hH<^%Gz%LOCK|L<g$18B

Sponsor Center